|
Giao Q. Phan, M.D., FACSAssociate Professor of Surgery
|
|
||||||||
Education
Post-Graduate Training
Awards
| Degree | Institution | Major |
|---|---|---|
| B.A. | Columbia University, Columbia College | Biochemistry |
| M.D. | Johns Hopkins University School of Medicine | Medicine |
Post-Graduate Training
| Training | Institution | Specialty |
|---|---|---|
| Residency | Ohio State University Medical Center | General Surgery |
| Fellowship | National Cancer Institute; National Institutes of Health | Immunotherapy and Surgical Oncology |
| Residency | Washington University in St. Louis/Barnes-Jewish Hospital | General Surgery |
| Fellowship | Moffitt Cancer Center | Surgical Oncology |
Awards
| Name of Award/Honor | Awarding Organization |
|---|---|
| Team Science Award, Cancer Immunotherapy and Biological Therapy, Society for Immunotherapy of Cancer (SITC) 25th Annual Meeting | Society for Immunotherapy of Cancer (SITC) |
| Medical Student Teaching Award, Department of Surgery | Washington University |
| Fellows Award for Research Excellence | National Institute of Health |
| American Society of Clinical Oncology Merit Award "Cancer Regression and Autoimmunity Induced by CTLA-4 Blockade in Patients with Metastatic Melanoma" | American Society of Clinical Oncology (ASCO) |
| American Society of Clinical Oncology Merit Award. "Quality of Life in Patients with Metastatic Renal Cell Cancer Receiving Different Regimens of Interleukin-2: A Randomized Trial" | American Society of Clinical Oncology (ASCO) |
| National Science Foundation Undergraduate Research Fellowship Department of Chemistry | Columbia University |
- Melanoma and Skin/Soft Tissue Cancers
- Thyroid and Parathyroid Diseases
- Immunotherapy
- Adoptive Cell Therapy
- Clinical Trials
Journal Articles
-
Neoadjuvant-Adjuvant or Adjuvant-Only Pembrolizumab in Advanced Melanoma.
The New England journal of medicine 2023 Mar;388(9):813-823